1ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The american college of rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes[J]. Arthritis Rheum, 1999,42:599-608.
2BORCHERS A T, AOKI C A, NAGUWA S M, et al. Neuropsychiatric features of systemic lupus erythematosus [J]. Autoimmun Rev, 2005,4 : 329-344.
3SANNA G, BERTOLACCINI M L, CUADRADO M J, et al. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibo dies[J]. J Rheumatol, 2003,30(5) :985-992.
4OSTANEK L, HONCZARENKO K, BRZOSKO M, et al. Antiphospholipid antibodies as a risk factor of neurological manifestations in patients with systemic lupus erythematosus [J]. Ann Rheum Dis, 2005(Suppl Ⅲ ) : 239.
5AVCIN T, BENSELER S M, TYRRELL P N, et al. A followup study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus [J]. Arthritis Rheum, 2008,59 (2) : 206-213.
7MATUS S, BURGOS P V, BRAVO-ZEHNDER M, et al.Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apop tosis[J]. J Eccp Med, 2007,204(13):3221-3234.
8KISS E, SHOENFELD Y. Are anti-ribosomal P protein antibodies relevant in systemic lupus erythematosus[J]. Clin Rev Allergy Immunol, 2007,32(1) :37-46.
9TIN S K, XU Q, THUMBOO J, et al. Novel brain reactive autoAbs: prevalence in systemic lupus erytematosus and asso ciation with psychoses and seizures[J]. Neuroimmunol, 2005, 169,153--160.
10OMDAL R, BROKSTAD K, WATERLOO K, et al. Neuro psychiatric disturbances in SLE are associated with Abs against NMDA receptors[J]. Eur J Neurol, 2005,12:392-398.
2Castellino G, Padovan M, Bortoluzzi A, et al. Single photon emission computed tomography and magnetic resonance imaging evaluation in SLE patients with and without neuropsychiatric involvement [ J ]. Rheumatology ( Oxford ) ,2008,47 ( 3 ) :319-323.
3Emmer B J, Steens SC, Steup-Beekman GM, et al. Detection of change in CNS involvement in neuropsychiatric SLE:a magnetization transfer study [ J ]. Magn Reson Imaging, 2006, 24 ( 4 ) : 812-816.
4Welsh RC, Rahbar H, Foerster B,et al. Brain diffusivity in patients with neuropsychiatric systemic lupus erythematosus with new acute neurological symptoms[ J ]. Magn Reson Imaging, 2007,26 ( 3 ): 541-551.
5Fitzqibbon BM, Fairhall SL, Kirki IJ, et al. Functional MRI in NPSLE patients reveals increased parietal and frontal brain activation during a working memory task compared with controls [ J ]. Rheumatology ( Oxford ) ,2008,47 ( 1 ) :50-53.
6Jose J, Paulose BK, Vasuki Z,et al. Mycophenolate mofetil in neuropsychiatric systemic lupus erythematosus [ J ]. Indian J Med Sci, 2005,59(8) :353-6.
7Valesini G, Priori R, Francia A, et al. Central nervous system involvement in systemic lupus erythematosus:a new therapeutic approach with intrathecal dexainethasone and methotremate [ J ]. Sp ringer Semin Immunopathol, 1994,16 ( 2/3 ) :313-321.
8Tokunaga M, Saito K, Kawabata D ,et al. Efficacy of rituximab( anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system [ J ]. Ann Rheum Dis, 2007, 66 ( 4 ) : 470-475.
9Leandro M J, Cambridge G, Edwards JC, et al. B cell depletion in the treatment of patients with systemic lupus erythematosus:a longitudinal analysis of 24 patients [ J ]. Rheumatology ( Oxford ), 2005,44 ( 12 ) : 1542-1545.
10Marks S,Patey S, Brogan PA ,et al. B lymphocyte depletion therapy in children with refractory systemic lupus erythematosus [ J ]. Arthritis Rheum,2005,52(10) :3168-3174.
